Holen Sie sich die Stockscreener-App
1.915
5.80%
0.105
Schlusskurs vom Vortag:
$1.81
Offen:
$1.83
24-Stunden-Volumen:
610.32K
Relative Volume:
0.54
Marktkapitalisierung:
$207.46M
Einnahmen:
$27.08M
Nettoeinkommen (Verlust:
$-37.00M
KGV:
-3.6827
EPS:
-0.52
Netto-Cashflow:
$-18.46M
1W Leistung:
-2.79%
1M Leistung:
+3.51%
6M Leistung:
+21.20%
1J Leistung:
+63.68%
1-Tages-Spanne:
$1.824
$1.94
1-Wochen-Bereich:
$1.805
$2.0684
52-Wochen-Spanne:
$1.05
$5.17
Aclaris Therapeutics Inc Stock (ACRS) Company Profile
Firmenname
Aclaris Therapeutics Inc
Sektor
Branche
Telefon
484-324-7933
Adresse
701 LEE ROAD, WAYNE, PA
Vergleichen Sie ACRS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACRS
Aclaris Therapeutics Inc
|
1.915 | 196.08M | 27.08M | -37.00M | -18.46M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
386.24 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.13 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.39 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
730.00 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.99 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Aclaris Therapeutics Inc Stock (ACRS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-05-28 | Eingeleitet | Wedbush | Outperform |
| 2025-03-18 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2024-12-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-11-20 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-11-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-11-19 | Hochstufung | Jefferies | Hold → Buy |
| 2024-11-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-11-18 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-01-22 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-10-03 | Eingeleitet | Evercore ISI | Outperform |
| 2022-12-14 | Eingeleitet | Stifel | Buy |
| 2022-12-01 | Eingeleitet | Goldman | Buy |
| 2022-10-06 | Eingeleitet | BTIG Research | Buy |
| 2021-07-23 | Fortgesetzt | Jefferies | Buy |
| 2021-06-15 | Eingeleitet | Piper Sandler | Overweight |
| 2021-04-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-10-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-09-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-27 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-05-06 | Eingeleitet | SVB Leerink | Outperform |
| 2018-03-28 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-02-09 | Eingeleitet | Guggenheim | Buy |
| 2017-06-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2016-11-29 | Eingeleitet | Leerink Partners | Outperform |
| 2016-09-30 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-06-10 | Eingeleitet | Guggenheim | Buy |
| 2015-11-02 | Eingeleitet | Citigroup | Buy |
| 2015-11-02 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Aclaris Therapeutics Inc Aktie (ACRS) Neueste Nachrichten
Aclaris Therapeutics Forms Scientific Advisory Board with Renowned Pulmonology Experts - MSN
Stock Analysis: What’s the outlook for Aclaris Therapeutics Inc.’s sectorShare Buyback & Low Risk Growth Stock Ideas - خودرو بانک
Geopolitics Watch: Whats the RSI of Aclaris Therapeutics Inc stockTrade Signal Summary & Short-Term Trading Opportunity Alerts - خودرو بانک
Acadian Asset Management LLC Buys 451,044 Shares of Aclaris Therapeutics, Inc. $ACRS - MarketBeat
Hedge Fund Bets: Is Aclaris Therapeutics Inc. a speculative investmentTake Profit & Growth Focused Stock Reports - خودرو بانک
Setup Watch: Is Aclaris Therapeutics Inc benefiting from innovation trends2025 Breakouts & Breakdowns & Long Hold Capital Preservation Tips - خودرو بانک
Performance Recap: Why is Aclaris Therapeutics Inc stock going upJuly 2025 Retail & AI Enhanced Execution Alerts - baoquankhu1.vn
Block Trades: Will Aclaris Therapeutics Inc. outperform the market in YEARJuly 2025 Summary & Verified Short-Term Plans - خودرو بانک
Momentum Shift: What is Vivani Medical Inc. s revenue forecastEarnings Risk Summary & Weekly High Return Stock Forecasts - خودرو بانک
Analyst Upgrade: Is Aclaris Therapeutics Inc.’s ROE strong enoughJuly 2025 Retail & Stepwise Swing Trade Plans - خودرو بانک
Will Aclaris Therapeutics Inc benefit from AI trends2025 Fundamental Recap & AI Optimized Trading Strategy Guides - خودرو بانک
Chart Watch: What is the earnings history of IGHGMarket Trend Review & Fast Momentum Stock Entry Tips - خودرو بانک
What is Aclaris Therapeutics Incs book value per share2025 Sector Review & Technical Entry and Exit Tips - خودرو بانک
Market Overview: Does FLWS meet Warren Buffetts criteriaTrade Signal Summary & Verified Swing Trading Watchlist - خودرو بانک
Aug Ideas: Is Aclaris Therapeutics Inc likely to announce a buyback2025 Market Sentiment & Precise Swing Trade Alerts - خودرو بانک
Analyst Downgrade: Will Aclaris Therapeutics Inc benefit from AI trendsPrice Action & Advanced Technical Analysis Signals - خودرو بانک
Strategies to average down on Aclaris Therapeutics Inc.New Guidance & Smart Allocation Stock Reports - newser.com
Real time scanner hits for Aclaris Therapeutics Inc. explainedJuly 2025 Final Week & Free Expert Approved Momentum Trade Ideas - newser.com
How to read the order book for Aclaris Therapeutics Inc.Entry Point & Free Technical Confirmation Trade Alerts - newser.com
Aclaris Therapeutics Inc.’s volatility index tracking explained2025 Market Sentiment & Daily Stock Trend Reports - newser.com
News impact scoring models applied to Aclaris Therapeutics Inc.Trade Exit Report & Community Consensus Picks - newser.com
Building trade automation scripts for Aclaris Therapeutics Inc.Gap Down & Fast Moving Stock Watchlists - newser.com
Detecting support and resistance levels for Aclaris Therapeutics Inc.Bear Alert & Safe Capital Growth Tips - newser.com
Published on: 2025-09-14 06:05:32 - newser.com
Best data tools to analyze Aclaris Therapeutics Inc. stock2025 Risk Factors & Reliable Breakout Forecasts - newser.com
Identifying reversal signals in Aclaris Therapeutics Inc.Quarterly Earnings Summary & Short-Term High Return Strategies - newser.com
Aclaris Therapeutics to Present New Data on Atopic Dermatitis Drug at EADV Congress - MyChesCo
real time scanner hits for aclaris therapeutics inc. explainedJuly 2025 EndofMonth & Reliable Price Action Trade Plans - newser.com
Jacobs Levy Equity Management Inc. Has $705,000 Position in Aclaris Therapeutics, Inc. $ACRS - Defense World
OMERS ADMINISTRATION Corp Grows Stake in Aclaris Therapeutics, Inc. $ACRS - MarketBeat
Aclaris to present additional data on atopic dermatitis drug at EADV - Investing.com Canada
Aclaris to present additional data on atopic dermatitis drug at EADV By Investing.com - Investing.com South Africa
Aclaris Therapeutics Announces Late-Breaking Abstract and - GlobeNewswire
Aclaris Therapeutics Announces Late-Breaking Abstract on Phase 2a Trial Results of ATI-2138 for Atopic Dermatitis at EADV Congress 2025 - Quiver Quantitative
Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 Phase 2a Results at the 2025 European Academy of Dermatology and Venereology (EADV) Congress - The Manila Times
Phase 2a Results: Aclaris' Novel ITK/JAK3 Inhibitor for Atopic Dermatitis at Major Dermatology Congress - Stock Titan
Can Aclaris Therapeutics Inc. deliver consistent dividendsJuly 2025 Levels & Precise Entry and Exit Recommendations - beatles.ru
Aclaris Therapeutics, Inc. $ACRS Shares Sold by Walleye Capital LLC - MarketBeat
Palo Alto Investors LP Buys 206,196 Shares of Aclaris Therapeutics, Inc. $ACRS - MarketBeat
What’s the recovery path for long term holders of Aclaris Therapeutics Inc.Quarterly Earnings Report & High Conviction Buy Zone Alerts - Newser
Will Aclaris Therapeutics Inc. benefit from rising consumer demandJuly 2025 Recap & Fast Moving Market Watchlists - خودرو بانک
Visual analytics tools that track Aclaris Therapeutics Inc. performanceQuarterly Trade Review & High Accuracy Trade Alerts - Newser
Will Aclaris Therapeutics Inc. outperform the market in YEARMarket Activity Recap & Short-Term Swing Trade Alerts - خودرو بانک
What’s the outlook for Aclaris Therapeutics Inc.’s sectorMarket Sentiment Summary & Weekly Watchlist for Hot Stocks - خودرو بانک
Aclaris Therapeutics to Present at Two Investor Conferences in September - MSN
Institution Moves: Is Aclaris Therapeutics Inc.’s ROE strong enoughTrade Entry Report & Capital Efficiency Focused Strategies - خودرو بانک
Is Aclaris Therapeutics Inc. likely to announce a buybackQuarterly Performance Summary & Weekly Top Stock Performers List - خودرو بانک
Will Aclaris Therapeutics Inc. face regulatory challenges2025 Short Interest & Weekly Breakout Stock Alerts - خودرو بانک
Can technical indicators confirm Aclaris Therapeutics Inc.’s reversalBear Alert & Low Risk High Win Rate Stock Picks - Newser
Aclaris Therapeutics Inc. recovery potential after sell off2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
Aclaris Therapeutics Inc. stock outlook for YEARWeekly Profit Recap & AI Optimized Trade Strategies - Newser
Finanzdaten der Aclaris Therapeutics Inc-Aktie (ACRS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aclaris Therapeutics Inc-Aktie (ACRS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mehra Anand | Director |
Nov 19 '24 |
Buy |
2.25 |
666,666 |
1,499,998 |
710,030 |
0.13%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):